"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","9/123","29/10891",1.84165200274811e-11,8.10326881209169e-09,6.51363234656174e-09,"CD27/EDA2R/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9",9
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","13/123","102/10891",1.02444129077118e-10,2.2537708396966e-08,1.81164354578483e-08,"CD27/EDA2R/LTBR/TNF/TNFRSF11A/TNFRSF12A/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9",13
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","12/123","134/10891",3.29979067456965e-08,4.83969298936883e-06,3.89027953212422e-06,"CD300C/CD300E/COLEC12/HLA-E/LAIR1/LILRB4/NCR3LG1/NECTIN2/NPDC1/OSCAR/PILRA/TREM2",12
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","8/123","47/10891",4.57842572649722e-08,5.03626829914694e-06,4.04829222132386e-06,"CD80/CSF1/IL10/IL10RB/IL1RN/TNF/TNFRSF1A/TNFRSF1B",8
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","5/123","19/10891",1.734756573022e-06,0.000152658578425936,0.000122711201796925,"ACE2/AGRN/CTSL/HAVCR1/HSPG2",5
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","9/123","108/10891",3.40587268658868e-06,0.000249763997016503,0.000200767232051543,"CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP4/SHISA5/SPP1/VCAN",9
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","8/123","85/10891",4.89958746367454e-06,0.000307974069145257,0.000247558103427766,"AGRN/BSG/COL18A1/COL6A3/COL9A1/HSPG2/ITGA11/SPP1",8
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","9/123","125/10891",1.13380463783951e-05,0.00062359255081173,0.000501260997781678,"CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP4/SHISA5/SPP1/VCAN",9
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","9/123","140/10891",2.81821879520315e-05,0.00137779585543265,0.00110751054407983,"BSG/COL18A1/COL6A3/COL9A1/CTSL/HSPG2/MMP12/MMP3/SPP1",9
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","13/123","300/10891",3.2924302862227e-05,0.00144866932593799,0.00116448060649561,"AGRN/BSG/COL18A1/COL6A3/COL9A1/CTSL/HSPG2/ITGA11/LTBP2/MMP12/MMP3/SPP1/VCAN",13
"R-HSA-9772572","R-HSA-9772572","Early SARS-CoV-2 Infection Events","5/123","38/10891",6.30721815334022e-05,0.00252288726133609,0.00202796679380126,"ACE2/AGRN/CTSL/HAVCR1/HSPG2",5
"R-HSA-1442490","R-HSA-1442490","Collagen degradation","6/123","64/10891",8.06169499320398e-05,0.00295595483084146,0.00237607852431275,"COL18A1/COL6A3/COL9A1/CTSL/MMP12/MMP3",6
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","5/123","41/10891",9.16540598073056e-05,0.00310213740886265,0.00249358413726758,"AGRN/B4GALT1/HSPG2/OGN/VCAN",5
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","5/123","45/10891",0.000144137096102907,0.00453002302037708,0.0036413582173366,"CD300E/CLEC5A/HLA-E/SIRPB1/TREM2",5
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","6/123","78/10891",0.000242874255897215,0.00712431150631831,0.00572671929694487,"AREG/CD80/EGFR/FGF23/FGFR2/TGFA",6
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","15/123","473/10891",0.000276193328785506,0.00759531654160141,0.00610532621525855,"CD80/CSF1/HAVCR2/IL10/IL10RB/IL15/IL18BP/IL18R1/IL1RN/IL2RA/LGALS9/MMP3/TNF/TNFRSF1A/TNFRSF1B",15
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","15/123","482/10891",0.000337796583380181,0.0087429703933694,0.00702784223007684,"B4GALT1/BST2/CD59/CHI3L1/CKAP4/CLEC5A/CST3/CSTB/LAIR1/LGALS3/OSCAR/PLAUR/RNASET2/SIRPB1/TNFRSF1B",15
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","3/123","13/10891",0.000370138212423383,0.00904782297034936,0.007272891191477,"AREG/EGFR/TGFA",3
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/123","14/10891",0.000467210015624238,0.0108196003618245,0.00869709502768665,"AREG/EGFR/TGFA",3
"R-HSA-5694530","R-HSA-5694530","Cargo concentration in the ER","4/123","33/10891",0.000492021758849083,0.0108244786946798,0.00870101636701537,"AREG/CD59/FOLR1/TGFA",4
"R-HSA-2022090","R-HSA-2022090","Assembly of collagen fibrils and other multimeric structures","5/123","61/10891",0.000607827589232827,0.0127354352029735,0.0102370962397108,"COL18A1/COL6A3/COL9A1/CTSL/MMP3",5
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","3/123","17/10891",0.00085146939806605,0.017029387961321,0.0136886946291958,"AREG/EGFR/TGFA",3
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3/123","18/10891",0.00101337537821069,0.0185785486005292,0.0149339529420522,"LTBR/TNFRSF11A/TNFRSF12A",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/123","18/10891",0.00101337537821069,0.0185785486005292,0.0149339529420522,"EGFR/GAST/MMP3",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","6/123","104/10891",0.00113095600681211,0.0196185872645497,0.0157699648825089,"AREG/CD80/EGFR/FGF23/FGFR2/TGFA",6
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","7/123","143/10891",0.00116157437503746,0.0196185872645497,0.0157699648825089,"AGRN/B4GALT1/HSPG2/OGN/SPON1/SPON2/VCAN",7
"R-HSA-419037","R-HSA-419037","NCAM1 interactions","4/123","42/10891",0.00124455145303067,0.0196185872645497,0.0157699648825089,"AGRN/COL6A3/COL9A1/GFRA1",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","6/123","106/10891",0.00124845555319862,0.0196185872645497,0.0157699648825089,"AREG/CD80/EGFR/FGF23/FGFR2/TGFA",6
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","3/123","20/10891",0.00139261344988846,0.0197661263855137,0.0158885609223268,"AGRN/HSPG2/VCAN",3
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","3/123","20/10891",0.00139261344988846,0.0197661263855137,0.0158885609223268,"AGRN/HSPG2/VCAN",3
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","3/123","20/10891",0.00139261344988846,0.0197661263855137,0.0158885609223268,"AGRN/HSPG2/VCAN",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","4/123","44/10891",0.00148344438333435,0.0203973602708473,0.0163959642368533,"HAVCR2/IL15/IL2RA/LGALS9",4
"R-HSA-3000178","R-HSA-3000178","ECM proteoglycans","5/123","76/10891",0.00165022597323508,0.0220030129764677,0.0176866324404142,"AGRN/COL6A3/COL9A1/HSPG2/VCAN",5
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","6/123","113/10891",0.00173461965390432,0.0224480190505265,0.0180443406721935,"AREG/CD80/EGFR/FGF23/FGFR2/TGFA",6
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/123","24/10891",0.0023924847008582,0.0300769505250745,0.0241766875034091,"AREG/EGFR/TGFA",3
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","4/123","51/10891",0.00257010209238376,0.0314123589069126,0.0252501258199106,"EFNA1/EFNA4/EPHA2/EPHB4",4
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","3/123","25/10891",0.002696493044944,0.0320664037777124,0.025775865237587,"AREG/EGFR/TGFA",3
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","3/123","26/10891",0.0030232876001127,0.035006488001305,0.0281391865273647,"AGRN/HSPG2/VCAN",3
"R-HSA-1474290","R-HSA-1474290","Collagen formation","5/123","90/10891",0.00346435499376982,0.0390850306989416,0.0314176323321636,"COL18A1/COL6A3/COL9A1/CTSL/MMP3",5
